Menu UF Health Home Menu
 

In the News

We invite you to learn more about the innovative efforts underway at the UF Diabetes Institute. Together, these important contributions strengthen our mission to improve the lives of all individuals impacted by this disease.

Haller-Michael_2907_Kiewel

Unlocking a combo therapy for new onset T1D, new trial announced

A new trial will determine whether a novel combination drug therapy works to reverse Type 1 diabetes in humans, building on UF findings reported earlier this year. UF Health pediatric endocrinologist Michael Haller, M.D., will serve as principal investigator for the new study. "Currently, there are no sufficient drug treatment options available that target diabetes in this way," Haller said. “If this larger trial produces similar results, this type of combination therapy will be a major advance in the treatment of type 1 diabetes.”

Walgreens

UF T1D research among JDRF’s Top 10 Research Advances in 2014

A collaborative Type 1 diabetes study led by researchers from UF and the Institute of Diabetes Research, Helmholtz Zentrum Munchen, in Germany was recently recognized among JDRF's Top 10 Research Advances in 2014. Bacterial interactions within the gut may influence T1D – building on the microbiome theory. Learn more.

Head Shot (2)

UF Diabetes Expert Speaks at National Continuing Education Conference

Ashby Walker, Ph.D., research assistant professor in the Department of Health Outcomes and Policy, recently presented at a national conference for nurse educators and physicians in Tampa, Fla., to discuss a recent UF photo research project, in which children with Type 1 diabetes were prompted to take and explain five pictures that captured what diabetes meant to them. The photos and explanations provide valuable perspectives and highlight the differences in disease experiences based on gender and socioeconomic status.

PicMonkey Collage2

Gator Engineer Brings $4.9 million to UF Diabetes Institute

Cherie Stabler, Ph.D., of the University of Florida College of Engineering, together with her team, recently won a $4.9 million grant to engineer a microchip that will serve to house islets that produce beta cells. Her team hopes to use the microchips to improve the current amount of islets available to transplant into patients with diabetes, as well as screen pharmaceuticals and create beta cells from stem cells.

otsp-placeholder

On the Same Page: The UF Diabetes Institute

In the latest issue of On the Same Page, UF Health president David S. Guzick, M.D. Ph.D. details the events leading up to the formation of the new UF Diabetes Institute — a collaboration of dozens of researchers campuswide all focused on forging new advances in treatment for a disease that afflicts an estimated 29.1 million Americans and 1 in 10 Floridians.

PicMonkey Collage

The University of Florida Diabetes Institute

Together, UF and UF Health are moving forward as national leaders in diabetes research, patient care, and innovation. Learn about the latest system-wide effort toward a collaborative approach toward the research and treatment of this disease.

Do-I-Qualify

ADA position statement addresses diabetes in child care setting

Type 1 diabetes care for children aged 5 years or younger requires unique management, according to a recent position statement in Diabetes Care. Authors stress that pediatric diabetes patients need a proactive disease care plan that involves clinicians, parents/guardians and child care staff. Researchers also highlighted hurdles in pediatric diabetes care, including language barriers, health literacy and ethnic and cultural practices.

Bill Nelson

UF diabetes and aging study recognized by U.S. Senator

U.S. Senator Bill Nelson, D-FL took note of a recent UF study authored by affiliate diabetes investigator Todd Manini, Ph.D. which highlights a link between sitting and risk for diabetes. "We must continue funding groundbreaking research like that at the University of Florida and promoting the kinds of lifestyle changes that will reduce the risks of diseases like diabetes in old age," he said.

3771A0CF-621F-43EC-8ECF10B11FF7B88B

Celiac screening for kids with type 1 diabetes

Several studies to date have found that people with type 1 diabetes (T1D) tend to have celiac disease more often than individuals in the general population. Michael Haller, MD, a pediatric endocrinologist at UF Health, told Medscape Medical News in a recent interview that screening every type 1 diabetes patient for the disease presents a unique clinical challenge.

baby blanket resize

Bacteria in the Gut Offer Clues to Diabetes

A new study co-authored by University of Florida diabetes researchers finds that bacteria in the guts of young children with type 1 diabetes are different from those of other kids. The research is helping clarify the importance of healthy gut bacteria development in early childhood and could help lead to novel prevention therapies for people at risk of developing the disease.

16621_10152812730258973_1330319603603185727_n

Screening for Gestational Diabetes

UF faculty in the Division of Obstetrics and Gynecology want to reduce the likelihood of further complications related to gestational diabetes, which occurs when pregnant women without a history of diabetes develop high blood glucose levels. A recent UF study with implications for all expectant mothers is the latest to shed light on this growing public health concern.

Cusi 150x150

Perspective: New Type 1 Diabetes Risk Factors

Kenneth Cusi, MD, adult medical director for the UF Diabetes Institute, recently gave his perspective on a small new study took the first step to demonstrate a link between non-alcoholic fatty liver disease (NAFLD) and an increased incidence of chronic kidney disease among type 1 diabetes patients. The editorial was published in the online magazine, EndocrineToday.

Mark-Atkinson-and-Desmond-Schatz-394x600

UF Researchers Named Among Top 10 International Type 1 Diabetes Experts

UF Diabetes Institute co-directors Mark Atkinson, PhD and Desmond Schatz, MD, are recognized as global leading authorities in the field of Type 1 diabetes mellitus. Together, their preeminent research contributions are shedding light on promising new therapies to treat and prevent this disease. Learn more about this outstanding achievement.


2014

2013